WC
DXCM icon

Westerkirk Capital’s DexCom DXCM Stock Holding History

Westerkirk Capital’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$411K Buy
+6,100
New +$406K 0.04% 160

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Westerkirk Capital's DXCM Position: Q2 2026 in Review

Westerkirk Capital opened a new position in DexCom (DXCM) in Q2 2026: 6,100 shares worth $411K. The stake represents 0.04% of the portfolio and ranks #160 among its holdings.

968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Westerkirk Capital held 6,100 shares of DexCom worth $411K as of Q2 2026.
  • DexCom was a new Westerkirk Capital position in Q2 2026.
  • DexCom made up 0.04% of Westerkirk Capital's portfolio in Q2 2026, its #160 holding.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Westerkirk Capital's 13F filing for Q2 2026, filed 10 Aug 2026.